Molecular and Translational Oncology - BioInn
The Moelcular and Translational Onconlogy division is based on the use of state-of-the-art genomic and bioinformatics technologies to characterize clinical samples under conventional therapy or clinical trials, to identify potential biomarkers for the diagnosis, prognosis and response prediction of different oncological pathologies. Furthermore, using highly specialized genetic manipulation methodologies, the genomic characteristics of these disorders are recreated in different models, in particular genetically modified mouse and cell models, which have the same genomic alterations as those identified in patients.
On the other hand, the Molecular and Translational Oncology division is also focused on the study of the tumor microenvironment and the processes that involve immune-stroma-tumor cell interactions and how these affect the response to antitumor therapies.
For more information, consult the Molecular and Translational Oncology division website.